Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis. [electronic resource]
Producer: 20120224Description: 1899-909 p. digitalISSN:- 1543-8392
- Animals
- Biological Transport
- Cell Line
- Cells, Cultured
- Cross-Linking Reagents -- chemistry
- Drug Carriers -- adverse effects
- Female
- Hepatic Stellate Cells -- drug effects
- Humans
- Interferon-gamma -- administration & dosage
- Ligands
- Liver Cirrhosis -- drug therapy
- Macrophage Activation -- drug effects
- Male
- Mice
- Mice, Inbred BALB C
- Peptides, Cyclic -- chemistry
- Receptor, Platelet-Derived Growth Factor beta -- metabolism
- STAT1 Transcription Factor -- metabolism
- Serum Albumin -- chemistry
- Serum Albumin, Human
- Signal Transduction -- drug effects
- Tissue Distribution
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.